Get notified when GRML files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Standing Risk Factors

  • Material Weakness (unchanged) — Material weaknesses in internal controls (inadequate accounting resources, lack of segregation of duties) persist as of March 31, 2026, with no change from the baseline filing.
  • Going Concern (unchanged) — Filing states that conditions raise substantial doubt about the company's ability to continue as a going concern. The same disclosure appeared in the baseline filing.
NASDAQ: GRML Greenland Mines Ltd 10-Q/A

GRML 10-Q/A corrects Q1 2026 net-loss narrative, adds $2.0M impairment on generic-drug licenses

Filed August 14, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 20, 2026 · ~1 min read

Key Financials

SEC XBRL

Period financials are unchanged from the original 10-Q (same period end Mar 31, 2026). This amendment updates disclosure only — see the diff below.

Key Changes

  • high

    Amendment discloses $2.0M non-cash impairment charge on generic-drug licenses (including four Encore-licensed drugs) deemed fully impaired after the Greenland Mines acquisition and strategic pivot to mining. Original 10-Q omitted this charge.

    MD&A: Operating Cash Flow verify on EDGAR →
  • high

    Original 10-Q incorrectly stated net loss 'decreased' when it widened from $2.1M to $13.9M YoY; amendment corrects narrative to reflect loss increase driven by share-based comp ($4.6M), professional fees ($2.2M), G&A, and warrant-liability revaluation.

    MD&A: Net Loss YoY verify on EDGAR →
  • high

    Amendment quantifies Q1 2026 G&A increase: $5.4M (630.6% YoY), split into $1.6M public-company costs and $4.6M share-based compensation. Original 10-Q described increase qualitatively without dollar breakouts.

    MD&A: G&A Expense Detail verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ZEO 10-Q) is open in full — no account needed.

Partner

Trade GRML commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 17, 2026 · How we verify